Cala Health Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $77M

  • Investors
  • 26

Cala Health General Information

Description

Developer of neuromodulation devices designed to optimize the standard of care for chronic diseases. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, enabling patients to reduce tremors and ensure relief.

Contact Information

Formerly Known As
Resido Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Corporate Office
  • 1800 Gateway boulevard
  • Suite 300
  • San Mateo, CA 94404
  • United States
+1 (888) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cala Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series D) 16-Nov-2021 $77M 00000 00000 Completed Generating Revenue
7. Later Stage VC (Series C) 21-May-2019 0000 000.00 00000 Completed Generating Revenue
6. Accelerator/Incubator 000.00 Completed Generating Revenue
5. Early Stage VC (Series B) 16-Feb-2016 0000 000.00 0000 Completed Generating Revenue
4. Early Stage VC (Series A) 02-Jul-2014 00.00 00.00 00.00 Completed Generating Revenue
3. Accelerator/Incubator Completed Startup
2. Spin-Off 01-Jan-2014 Completed Startup
1. Grant 01-Jan-2013 $35K Completed Startup
To view Cala Health’s complete valuation and funding history, request access »

Cala Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 28,946,332 $0.000100 $0.08 $1.04 $1.04 1x $1.04 19.02%
Series A 8,208,955 $0.000100 $0.03 $0.4 $0.4 1x $0.4 5.39%
To view Cala Health’s complete cap table history, request access »

Cala Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neuromodulation devices designed to optimize the standard of care for chronic diseases. The company's weara
Therapeutic Devices
San Mateo, CA
78 As of 2023
00000
00000 0000-00-00
00000000000 00000

000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
00000000000 0000000
Eindhoven, Netherlands
00 As of 0000
000.00
000000000000 000.00

000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla par
00000000000 0000000
Artarmon, Australia
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cala Health Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Salvia BioElectronics Venture Capital-Backed Eindhoven, Netherlands 00 000.00 000000000000 000.00
Saluda Medical Venture Capital-Backed Artarmon, Australia 000 00000 00000000000 00000
Fisher Wallace Labs Venture Capital-Backed New York, NY 0 0000 000000000000 0000
Aleva Neurotherapeutics Private Equity-Backed Lausanne, Switzerland 00 000.00 00 000000 000.00
ZetrOZ Venture Capital-Backed Trumbull, CT 00 000.00 0000000000 000.00
You’re viewing 5 of 51 competitors. Get the full list »

Cala Health Patents

Cala Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022324555-A1 Wearable neurostimulation system Pending 03-Aug-2021 000000000
AU-2022325136-A1 Parameter variations in neural stimulation Pending 03-Aug-2021 00000000000
CA-3226913-A1 Wearable neurostimulation system Pending 03-Aug-2021 000000000
EP-4380677-A2 Parameter variations in neural stimulation Pending 03-Aug-2021 00000000000
EP-4380673-A1 Wearable neurostimulation system Pending 03-Aug-2021 A61B5/369
To view Cala Health’s complete patent history, request access »

Cala Health Executive Team (10)

Name Title Board Seat Contact Info
Deanna Harshbarger Co-Chief Executive Officer & President
Kate Rosenbluth Ph.D Chief Innovation Officer & President & Board Member
Renee Ryan Co-Chief Executive Officer, President and Board Member
Scott Delp Ph.D Co-Founder, Chairman of Scientific Advisory Board & Board Observer
You’re viewing 4 of 10 executive team members. Get the full list »

Cala Health Board Members (11)

Name Representing Role Since
John Kuelper JD Ascension Ventures Board Member 000 0000
Juan-Pablo Mas Action Potential Venture Capital Board Member 000 0000
Michael Carusi Lightstone Ventures Board Member 000 0000
Neil Tiwari Novartis Pharma Board Member 000 0000
Scott Delp Ph.D Self Co-Founder, Chairman of Scientific Advisory Board & Board Observer 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Cala Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cala Health Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ascension Ventures Corporate Venture Capital Minority 000 0000 000000 0
Dolby Family Ventures Venture Capital Minority 000 0000 000000 0
Innovatus Capital Partners Asset Manager Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
Magnetar Capital Hedge Fund Minority 000 0000 000000 0
You’re viewing 5 of 26 investors. Get the full list »

Cala Health FAQs

  • When was Cala Health founded?

    Cala Health was founded in 2013.

  • Who is the founder of Cala Health?

    Kate Rosenbluth Ph.D, Serena Wong Ph.D, and Scott Delp Ph.D are the founders of Cala Health.

  • Who is the CEO of Cala Health?

    Deanna Harshbarger and Renee Ryan are the CEOs of Cala Health.

  • Where is Cala Health headquartered?

    Cala Health is headquartered in San Mateo, CA.

  • What is the size of Cala Health?

    Cala Health has 78 total employees.

  • What industry is Cala Health in?

    Cala Health’s primary industry is Therapeutic Devices.

  • Is Cala Health a private or public company?

    Cala Health is a Private company.

  • What is the current valuation of Cala Health?

    The current valuation of Cala Health is 00000.

  • What is Cala Health’s current revenue?

    The current revenue for Cala Health is 000000.

  • How much funding has Cala Health raised over time?

    Cala Health has raised $161M.

  • Who are Cala Health’s investors?

    Ascension Ventures, Dolby Family Ventures, Innovatus Capital Partners, Johnson & Johnson Innovation - JLABS, and Magnetar Capital are 5 of 26 investors who have invested in Cala Health.

  • Who are Cala Health’s competitors?

    Salvia BioElectronics, Saluda Medical, Fisher Wallace Labs, Aleva Neurotherapeutics, and ZetrOZ are some of the 51 competitors of Cala Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »